Literature DB >> 18042171

Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host.

D Correa1, I Cañedo-Solares, L B Ortiz-Alegría, H Caballero-Ortega, C P Rico-Torres.   

Abstract

The apicomplexan parasite Toxoplasma gondii is remarkable in several aspects, since it is a protozoan that infects most nucleated cells in many warm-blooded animals, worldwide. Although the cellular immune response against T. gondii is critical for infection control, antibodies may either enhance or block protective mechanisms, and even mediate immunological damage, directly or indirectly. Since cytokines regulate the class/subclass switch, antibodies may also be the biomarkers of protective or pathological cellular immune events. There is a scientific and clinical interest in the presence of natural and autoreactive antibodies, as well as in the 'chronic' immunoglobulin M (IgM) response and the post-treatment 'rebound'. Another interesting aspect is compartmentalization; certain immunoglobulins may uniquely be found in specific host fluids. Local synthesis has been demonstrated, but antibodies may also traverse several cell layers, like the blood-brain and haemato-ocular barriers, and the placenta. In some instances, Fc receptors (FcRs) facilitate transport and may even have a concentrator effect, which can be related to resistance or pathology. These aspects of the humoral response against T. gondii are reviewed in the present paper.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042171     DOI: 10.1111/j.1365-3024.2007.00982.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  32 in total

1.  Comprehensive proteomic analysis of membrane proteins in Toxoplasma gondii.

Authors:  Fa-Yun Che; Carlos Madrid-Aliste; Berta Burd; Hongshan Zhang; Edward Nieves; Kami Kim; Andras Fiser; Ruth Hogue Angeletti; Louis M Weiss
Journal:  Mol Cell Proteomics       Date:  2010-10-10       Impact factor: 5.911

Review 2.  Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review.

Authors:  C P Rico-Torres; J A Vargas-Villavicencio; D Correa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-04       Impact factor: 3.267

3.  Molecular cloning and characterization of mitogen-activated protein kinase 2 in Toxoplasma gondii.

Authors:  Huan Huang; Yan Fen Ma; Yi Bao; Hattie Lee; Michael P Lisanti; Herbert B Tanowitz; Louis M Weiss
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

4.  Altered endochondral ossification in collagen X mouse models leads to impaired immune responses.

Authors:  E Sweeney; M Campbell; K Watkins; C A Hunter; O Jacenko
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

5.  Induction of mitotic S-phase of host and neighboring cells by Toxoplasma gondii enhances parasite invasion.

Authors:  Mark D Lavine; Gustavo Arrizabalaga
Journal:  Mol Biochem Parasitol       Date:  2008-12-06       Impact factor: 1.759

6.  Toxoplasma-SPECIFIC IgG SUBCLASS ANTIBODY RESPONSE IN CEREBROSPINAL FLUID SAMPLES FROM PATIENTS WITH CEREBRAL TOXOPLASMOSIS.

Authors:  Fernanda S Nascimento; Lisandra A Suzuki; Nilson Branco; Regina M B Franco; Paula D Andrade; Sandra C B Costa; Marcelo N Pedro; Cláudio L Rossi
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Sep-Oct       Impact factor: 1.846

Review 7.  Immune response and immunopathology during toxoplasmosis.

Authors:  Christopher D Dupont; David A Christian; Christopher A Hunter
Journal:  Semin Immunopathol       Date:  2012-09-07       Impact factor: 9.623

8.  Autoantibodies Against Ubiquitous and Confined Antigens in Patients With Ocular, Neuro-Ophthalmic and Congenital Cerebral Toxoplasmosis.

Authors:  Monica Goldberg-Murow; Carlos Cedillo-Peláez; Luz Elena Concha-Del-Río; Rashel Cheja-Kalb; María José Salgar-Henao; Eduardo Orozco-Velasco; Héctor Luna-Pastén; Fernando Gómez-Chávez; Antonio Ibarra; Dolores Correa
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

9.  Toxoplasma gondii Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant.

Authors:  Zhengqing Yu; Wenxi Ding; Muhammad Tahir Aleem; Junzhi Su; Junlong Liu; Jianxun Luo; Ruofeng Yan; Lixin Xu; Xiaokai Song; Xiangrui Li
Journal:  Pharmaceutics       Date:  2021-05-19       Impact factor: 6.321

10.  Immunosuppression with cyclophosphamide favors reinfection with recombinant Toxoplasma gondii strains.

Authors:  L A Silva; G P Brandão; B V Pinheiro; R W A Vitor
Journal:  Parasite       Date:  2012-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.